Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood

References

• Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994;1:333–9.
   PubMedGoogle Scholar
• Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women > or = 62 years of age. Am J Cardiol 1994;74:64–5.
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324(7329):71–86.
   Google Scholar
• De la Cruz JP, Sa´nchez de la Cuesta F. Does the association dipyridamole-aspirin only act by a functional synergism? Gen Pharmacol 1991;22(2):271–4.
   Google Scholar
• Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study.2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143 (1-2): 1–13.
   Google Scholar
• Forbes CD. Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combina- tion. ESPS Investigators. European Stroke Prevention Study. Thromb Res 1998;92(Suppl. 1): S1-6.
   Google Scholar
• Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willet WC. Vitamin E consumption and the risk of coronary disease in women. New Engl J Med 1993;328:1444–9.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC. Vitamin E consumption and the risk of coronary disease in men. New Engl J Med 1993;328:1450–6.
   PubMed Web of Science ®Google Scholar
• Mitchinson MJ, Stephens NG, Parsons A, Bligh E, Schofield PM, Brown MJ. Mortality in the CHAOS trial. Lancet 1999;353:381–2.
   PubMedGoogle Scholar
• Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combi- nations, cancer incidence and disease specific mortality in the general population. J Natl Cancer Inst 1993;85:1483–92.
   Google Scholar
• Virtamo J, Rapola JM, Ripalti S, Heirnonen OP, Taylor PR, Albanes K, Huttunen JK. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 1998;158:668–75.
   PubMed Web of Science ®Google Scholar
• Celestini A, Pulcinelli FM, Pignatelli P, Lenti L, Frati G, Gazzaniga PP, Violi F. Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets. Haematologica 2002;87:420–6.
   PubMedGoogle Scholar
• Steiner M, Glantz M, Lekos A. Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. Am J Clin Nutr 1995; 62:1381-4S.
   Google Scholar
• Cardinal DC, Flowers JR. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharm Methods 1980;3:135–8.
   PubMedGoogle Scholar
• Shibuki K, Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature 1991;349:326–8.
   PubMed Web of Science ®Google Scholar
• Higashi O, Kikuchi Y. Effects of vitamin E on the aggregation and lipid peroxidation of platelets exposed to hydrogen peroxide. Tohoku J Exp Med 1974;112:271–8.
   PubMedGoogle Scholar
• Calzada C, Bruckdorfer K, Rice Evans C. The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis 1997;128:97–105.
   PubMed Web of Science ®Google Scholar
• Takamatsu S, Takamatsu M, Satoh K. Effects on health of dietary supplementation with 100 mg 8-a-tocopheryl acetate, daily for 6 years. J Int Med Res 1995;23:342–57.
   PubMedGoogle Scholar
• Marcus AJ. Thrombosis and inflammation as multicelular processes: significance of cell-cell interactions. Semin Haematol 1994;31(4):261–9.
   PubMedGoogle Scholar
• De Gaetano G, Evangelista V, Rajtar G, Del Maschio A, Cerletti A. Activated polymorphonuclear leucocytes stimulate platelet function. Thromb Res 1990;Suppl XI:32–.
   Google Scholar
• Lopez-Farre A, Caramelo C, Esteban A, Alberola ML, Millas I, Monton M, Casado S. Effects of aspirin on platelet- neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation 1995;91(7):2080–8.
   Google Scholar
• De la Cruz JP, Blanco E, Sa´nchez de la Cuesta F. Effect of dipyridamole and aspirin on the platelet-neutrophil interaction via the nitric oxide pathway. Eur J Pharmacol 2000;397(1):35–41.
   Google Scholar
• De la Cruz JP, Bellido I, Camara S, Martos F, Sa´nchez de la Cuesta F. Effects of acetylsalicylic acid on platelet aggregation in male and female whole blood: an in vitro study. Scand J Haematol 1986;36(4):394–7.
   Google Scholar
• De la Cruz JP, Camara S, Bellido I, Carrasco T, Sa´nchez de la Cuesta F. Platelet aggregation in human whole blood after chronic administration of aspirin. Thromb Res 1987;46(1):133–40.
   Google Scholar
• Savage B, Cattaneo M, Ruggeri ZM. Mechanisms of platelet aggregation. Curr Opin Hematol 2001;8(5):270–6.
   PubMed Web of Science ®Google Scholar
• Steiner M, Anastasi J. Vitamin E: an inhibitor of the platelet release reaction. J Clin Invest 1976;57:732–7.
   PubMed Web of Science ®Google Scholar
• Ferns GA, Forster LA, Williams JC, Tull SP, Verma PK, Starkey B, Gershlick AH. Effect of vitamin E supplementation on circulating cell adhesion molecules pre- and post-coronary angioplasty. Ann Clin Biochem 2000;37(Pt.5):54–.
   Google Scholar
• Pryor WA. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000;28(1):141–64.
   PubMedGoogle Scholar
• Freedman JE, Farhat JH, Loscalzo J, Keaney JF. a-Tocopherol inhibits aggregation of human platelets by protein kinase C-dependent mechanism. Circulation 1996;94:2434–40.
   PubMed Web of Science ®Google Scholar
• Kroll MH, Hellums JD, Guo Z, Durante W, Razdan D, Hrbolich JK, Schafer AI. Protein kinase C is activated in platelets subjected to pathological shear stress. J Biol Chem 1993;268:3520–4.
   PubMedGoogle Scholar
• Freedman JE, Keany JF. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity. J Nutr 2001;131:374-7S.
   Google Scholar
• Liu M, Wallmon A, Olson-Morlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potencial mechanisms. Am J Clin Nutr 2003;77:700–6.
   PubMed Web of Science ®Google Scholar
• Vane JR. The mode of action os aspirin-like drugs. Agents Actions 1978;8(4):430–1.
   PubMedGoogle Scholar
• Agradi E, Petroni A, Socini A, Galli C. In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation. Prostaglandins 1981;22(2):255–66.
   PubMedGoogle Scholar
• Sheu JR, Lee CR, Hsiao G, Hung WC, Lee YM, Chen YC, Yen MH. Comparison of the relative activities of a-tocopherol and PMC on platelet aggregation and antioxidative activity. Life Sci 1999;65(2):197–206.
   PubMedGoogle Scholar
• Gryglewski RJ, Szczeklik A. Inhibition of prostacyclin forma- tion by lipid peroxides in the arterial wall: hypothetical step in development of atherosclerosis. Mater Med Pol 1978;10(4):338–41.
   PubMedGoogle Scholar
• Li D, Saldeen T, Romeo F, Mehta JL. Different isoforms of tocopherols enhance nitric oxide synthase phosphorylation and inhibit human platelet aggregation and lipid peroxidation: implications in therapy with vitamin E. Cardiovasc Pharmacol Ther 2001;6(2):155–61.
   PubMedGoogle Scholar
• Keaney JF, Simon DI, Freedman JE. Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J 1999;13:965–76.
   PubMed Web of Science ®Google Scholar
• Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, Moriyama Y. Vitamin E adminis- tration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998;32(6):1672–9.
   PubMedGoogle Scholar
• Keaney JF, Guo Y, Cunningham D, Shwaery GT, Xu A, Vita JA. Vascular incorporation of a-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest 1996;98(2):386–94.
   PubMedGoogle Scholar